Jaime Moy

Jaime Moy has a diverse work experience spanning multiple industries. They started their career at PricewaterhouseCoopers LLP as a Strategy Consultant from 1999 to 2001. After that, they joined The Advisory Board Company and held the role of Director New Product Development and Associate Director H*Works Consulting from 2002 to 2005. They then transitioned to the pharmaceutical industry, working at Amgen from 2007 to 2020. At Amgen, they took on various roles, including New Product Development Lead in Oncology, Reimbursement Access and Value Director, Strategic Planning and Operations Director, and senior positions in marketing and promotions. In 2020, Jaime joined Theravance Biopharma US, Inc. as an Executive Director, managing commercial operations strategy for key pipeline assets and serving as a Product Team Lead for a phase 3 rare disease neurology asset. In 2022, they moved to FibroGen, Inc. as the Head of Market Access, and in 2023, they returned to Theravance Biopharma US, Inc. as the VP of Commercial Strategy.

Jaime Moy has an MBA degree with a Healthcare Management and Marketing Major from The Wharton School. Additionally, Jaime holds a Bachelor of Arts degree in Economics and Mathematics from Northwestern University.